Literature DB >> 11600084

Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study.

N Berhe1, A Hailu, Y Abraham, Y Tadesse, K Breivik, Y Abebe.   

Abstract

From July 1989 up to September 1997, a total of 247 non-HIV associated visceral leishmaniasis (VL) patients were treated on outpatient basis in rural clinics (195 patients) and hospitalised in the Northern-Omo Regional Hospital (18 patients) and in Addis Ababa referral hospitals (34 patients). Patients treated in the rural clinics and in the Regional hospital originated from the same endemic area and had comparable baseline characteristics. Overall rates of complications (inter-current/concurrent infectious or non-infectious diseases or deaths) in the three categories were 10.7, 38.9 and 61.6%, while case fatality rates were 2.5, 5.6 and 11.7%, respectively. Nosocomial bacterial infections occurred in 16.6% of patients treated in the Regional hospital and 32.3% of patients treated in Addis Ababa referral hospitals, and these infections accounted for 42.8 and 52.4% of the complications seen in the respective categories. Among VL patients originating from the same endemic place and with comparable baseline clinical data, patients treated hospitalised had significantly higher rates of complications than patients treated on outpatient basis (P<0.001). Patients who had complications during the course of VL therapy had significantly lower pre-treatment haemoglobin levels. Considering the extra cost of hospitalisation and risk of nosocomial infections and petavalent antimonial therapy being fairly safe, we recommend that VL patients, unless with serious complications, should preferably be treated on ambulatory basis with follow-up to monitor response and inter-current infections if any.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600084     DOI: 10.1016/s0001-706x(01)00156-5

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  5 in total

1.  In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major.

Authors:  Hany M Yehia; Ebtesam M Al-Olayan; Manal F El-Khadragy; Dina M Metwally
Journal:  Int J Environ Res Public Health       Date:  2017-07-13       Impact factor: 3.390

2.  Pediatric visceral leishmaniasis in Tartous, Syria.

Authors:  Ali Othman Hamwi; Ali Abdallatif Mohammad; Sara Othman Hamwi; Razan Abdallatif Mohammad; Kayss Younis Shahin
Journal:  Avicenna J Med       Date:  2020-10-13

3.  Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia.

Authors:  Mengistu Endris; Yegnasew Takele; Desalegn Woldeyohannes; Moges Tiruneh; Rezika Mohammed; Feleke Moges; Lutgarde Lynen; Jan Jacobs; Johan van Griensven; Ermias Diro
Journal:  Biomed Res Int       Date:  2014-05-06       Impact factor: 3.411

4.  Healthcare-associated infection and its determinants in Ethiopia: A systematic review and meta-analysis.

Authors:  Abebaw Yeshambel Alemu; Aklilu Endalamaw; Demeke Mesfin Belay; Demewoz Kefale Mekonen; Biniam Minuye Birhan; Wubet Alebachew Bayih
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

Review 5.  The burden of healthcare-associated infection in Ethiopia: a systematic review and meta-analysis.

Authors:  Abebaw Yeshambel Alemu; Aklilu Endalamaw; Wubet Alebachew Bayih
Journal:  Trop Med Health       Date:  2020-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.